Minaxolone

This classification denotes an anesthetic agent with the molecular formula C25H43NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 737SKC73L0, chemically known as pregnan-20-one, 11-(dimethylamino)-2-ethoxy-3-hydroxy-, (2beta,3alpha,5alpha,11alpha)- but generally known as minaxolone, which bears US NIH Compound Identifier 71960. European Medicines Agency schedules Minaxolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08975MIG. The term MINAXOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). MINAXOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule minaxolone under HS 29225000 and SITC 51467. As of Q4 2014, MINAXOLONE remains the US FDA Preferred Term for this commodity. Minaxolone bears US NLM identifiers UMLS ID C0066562 and NCI Concept Code C87596. SMILES: O(C1CC2(C3C(C4C(CC3N(C)C)(C(CC4)C(=O)C)C)CCC2CC1O)C)CC.